Limosilactobacillus fermentum modulates the gut-airway axis by improving the immune response through FOXP3 activation on combined allergic rhinitis and asthma syndrome (CARAS)

• Published in: Immunobiology (1979) Vol. 228; no. 5; p. 152721
• Main Authors: Cavalcanti, Raquel F.P., Gadelha, Francisco A.A.F., Paiva Ferreira, Laércia K.D., Paiva Ferreira, Larissa A.M., Chaves Júnior, José V., de Araújo Batista, Rayanne S., Melo, Taynara B.L., de Souza, Fábio S., Alves, Adriano F., Maria Batista, Leônia, Piuvezam, Marcia R.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier GmbH 01.09.2023
• Subjects: Allergy; Immunomodulatory effect; Limosilactobacillus fermentum; Probiotics; Transcription factor; Allergy; Probiotics; Limosilactobacillus fermentum; Immunomodulatory effect; Transcription factor
• ISSN: 0171-2985; 1878-3279
• DOI: 10.1016/j.imbio.2023.152721

Combined allergic rhinitis and asthma syndrome (CARAS) is an allergic airway inflammatory disorder orchestrated by the type 2 immune response. The close gut-lung relationship has been described, however, the effect of gut-modulating agents such as probiotics in allergic airway disorder is unclear. Thus, the goal of this study was to evaluate theLimosilactobacillus fermentumsupplementation in animals with CARAS. Therefore, BALB/c mice were ovalbumin (OVA) -sensitized and -challenged after being supplemented withL. fermentum. Animals, previously probiotic supplemented, showed a decrease (p < 0.05) of inflammatory cell migration, mainly eosinophil, into the nasal (NALF) and the bronchoalveolar (BALF) fluids as well as reduction of the allergic signs such as sneezing, nasal rubbings, and nasal hyperreactivity induced by histamine as compared with non-supplemented animals. In the systemic context,L. fermentumreduced eosinophilia and the serum levels of OVA-specific IgE. The altered histological aspects of nasal and lung tissues of animals with CARAS were effectively ameliorated byL. fermentum. In the BALF, the immunomodulatory effect was due to the decreasing of type 2 and 3 cytokines (IL-4, IL-13, IL-5 and IL-17A) dependent on type 1 (IFN-γ) and Treg (IL-10) cytokine increasing. Indeed,L. fermentumimproved the FOXP3 activation. Additionally, these effects correlate with the amplification of the gut response as increasing short-chain fatty acids (SCFAs) levels, gut epithelium barrier (ZO-1) maintenance, and colon tissue integrity. These data pointed out that animals’ probiotic supplemented presented immunomodulatory responses in CARAS experimental model by activating the intracellular transduction signal underlying the IL-10 gene transcription.